NorthView Acquisition Corporation (NVAC) Stock Analysis
DELISTED 2025
What happened to NorthView Acquisition Corporation (NVAC) stock?
NorthView Acquisition Corporation (NVAC) no longer trades on public markets. It was delisted in July 2025. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NorthView Acquisition Corporation (NVAC) trades at $2.50. NorthView Acquisition Corporation is a shell company focused on merging with a business in the healthcare sector. Currently, the company does not have significant operations. Market cap: $13.4M, Sector: Financial services.
Last analyzed: Mar 17, 2026Analyst Coverage for NVAC: NVAC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NVAC against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
NVAC: 1/2 scored disciplines lean bearish. Dominant signal: Jim Simons bearish.
How is this calculated? →NorthView Acquisition Corporation (NVAC) Financial Services Profile
NorthView Acquisition Corporation, a shell company incorporated in 2021, is actively seeking a merger, asset acquisition, or similar business combination, primarily focusing on targets within the healthcare sector. The company currently has no significant operations and functions as a special purpose acquisition company (SPAC).
What Is the Investment Thesis for NVAC?
NorthView Acquisition Corporation presents a speculative investment opportunity, contingent on its ability to identify and successfully merge with a promising healthcare company. The company's value is currently tied to its cash reserves and the potential upside from a future acquisition. Key considerations include the management team's expertise in deal sourcing and execution, the attractiveness of the target company, and the prevailing market conditions for SPAC transactions. The absence of current operations makes it difficult to assess intrinsic value, with the investment thesis largely dependent on the future target's performance. Investors should carefully evaluate the risks associated with SPAC investments, including potential dilution, deal execution challenges, and market volatility.
Based on FMP financials and quantitative analysis
NVAC Key Highlights
Market capitalization of $13.4M reflects the company's current status as a shell corporation.
- Negative P/E ratio of -0.01 indicates the company's lack of profitability due to the absence of significant operations.
- Beta of 0.02 suggests low volatility relative to the broader market, typical for a shell company awaiting a merger.
- Absence of dividend yield reflects the company's focus on identifying and acquiring a target business rather than distributing profits.
- Focus on the healthcare sector aligns with industry growth trends and potential for innovation-driven value creation.
Who Are NVAC's Competitors?
NVAC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ECGR Bellatora Inc. | $0.80 | +17.65% | $13.4M | 49 |
| FWAV Fourth Wave Energy, Inc. | $0.04 | +0.00% | $15.4M | 38 |
| GTVI Joway Health Industries Group Inc. | $0.07 | +4.43% | $15.3M | 44 |
| KBPH Kyto Technology and Life Science, Inc. | $1.00 | -45.65% | $13.3M | 38 |
| NIHL New Infinity Holdings, Ltd. | $0.10 | +0.00% | $10.8M | 62 |
| LRGR Luminar Media Group, Inc. | $0.50 | +47.06% | $22.4M | 68 |
| CLAYU Chavant Capital Acquisition Corp. | $10.97 | +18.34% | $27.5M | 62 |
| CLAY Chavant Capital Acquisition Corp. | $10.66 | +6.39% | $29.6M | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NVAC's Key Strengths?
Experienced management team.
- Dedicated focus on the healthcare sector.
- Access to capital through the IPO.
- Flexibility to pursue various transaction structures.
What Are NVAC's Weaknesses?
Lack of current operations.
- Dependence on identifying and acquiring a suitable target.
- Competition from other SPACs.
- Potential for dilution through future equity offerings.
What Could Drive NVAC Stock Higher?
Announcement of a definitive merger agreement with a target company in the healthcare sector.
- Progress in negotiations with potential acquisition targets.
- General market sentiment towards SPACs and healthcare investments.
What Are the Key Risks for NVAC?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Failure to identify and complete a merger or acquisition within the specified timeframe.
- Dilution of shareholder value through future equity offerings.
- Economic downturn impacting the healthcare sector.
- Increased regulatory scrutiny of SPACs.
- Competition from other SPACs seeking attractive targets.
What Are the Growth Opportunities for NVAC?
- Successful Acquisition: NorthView Acquisition Corporation's primary growth opportunity lies in identifying and acquiring a high-growth healthcare company. A successful acquisition would provide NorthView Acquisition Corporation with immediate revenue and earnings, transforming it from a shell company into an operating business. The timeline for this growth opportunity is dependent on the company's ability to find and close a deal, typically within 12-24 months of its IPO.
- Operational Improvements: Post-acquisition, NorthView Acquisition Corporation can drive growth by implementing operational improvements within the acquired company. This includes streamlining processes, reducing costs, and optimizing resource allocation. The potential for operational improvements varies depending on the target company's existing efficiency and management practices. This growth opportunity can be realized within the first 1-3 years following the acquisition.
- Strategic Expansion: Following a successful acquisition, NorthView Acquisition Corporation can pursue strategic expansion initiatives, such as entering new markets, launching new products, or making complementary acquisitions. The size of the market for these expansion opportunities depends on the specific industry and geographic focus of the acquired company. This growth opportunity can be pursued in the medium to long term, typically 3-5 years after the initial acquisition.
- Technological Innovation: By focusing on the healthcare sector, NorthView Acquisition Corporation can capitalize on technological innovation and disruption. This includes investing in companies that are developing new medical devices, diagnostic tools, or digital health solutions. The market for healthcare technology is rapidly growing, driven by increasing demand for personalized and preventative care. This growth opportunity can be realized through strategic partnerships, investments, or acquisitions of innovative companies.
- Regulatory Tailwinds: The healthcare sector is subject to evolving regulations and policies, which can create opportunities for growth. For example, changes in reimbursement models, healthcare reform initiatives, or drug approval processes can benefit certain companies within the sector. NorthView Acquisition Corporation can position itself to capitalize on these regulatory tailwinds by investing in companies that are well-positioned to navigate the changing regulatory landscape. The timeline for this growth opportunity is dependent on the timing and impact of regulatory changes.
What Are NVAC's Competitive Advantages?
- Management team's experience in deal sourcing and execution.
- Access to capital through the IPO.
- Focus on the healthcare sector, which offers high growth potential.
- Ability to provide a faster and more efficient route to public markets than a traditional IPO.
What Does NVAC Do?
NorthView Acquisition Corporation, established in 2021 and based in New York, operates as a special purpose acquisition company (SPAC). As a shell company, NorthView Acquisition Corporation's primary objective is to identify and merge with an existing business, facilitating its entry into the public market. The company's strategy involves pursuing a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. NorthView Acquisition Corporation intends to focus its search on businesses within the healthcare sector, leveraging potential growth and innovation in the industry. Currently, NorthView Acquisition Corporation does not have significant operations, existing solely to identify and complete a qualifying transaction. The company is a subsidiary of NorthView Sponsor I, LLC, which provides the necessary capital and expertise to execute its strategic objectives. Upon successful completion of a merger or acquisition, NorthView Acquisition Corporation aims to drive shareholder value through the acquired company's operations and growth initiatives.
What Products and Services Does NVAC Offer?
- NorthView Acquisition Corporation is a blank check company.
- They seek to merge with a private company to take it public.
- Their focus is on finding a target in the healthcare sector.
- They offer a faster route to public markets than a traditional IPO.
- They provide capital and expertise to the acquired company.
- They aim to create value for shareholders through the acquired company's growth.
How Does NVAC Make Money?
- Raise capital through an initial public offering (IPO).
- Identify and merge with a private company in the healthcare sector.
- The acquired company then operates as a publicly traded entity under the NorthView Acquisition Corporation ticker.
- Generate returns for shareholders through the acquired company's growth and profitability.
What Industry Does NVAC Operate In?
NorthView Acquisition Corporation operates within the shell company industry, specifically as a SPAC. SPACs have gained prominence as alternative routes for private companies to go public, bypassing the traditional IPO process. The industry is characterized by intense competition among SPACs seeking attractive targets, particularly in high-growth sectors like healthcare. Market trends include increased regulatory scrutiny and investor demand for SPACs with experienced management teams and well-defined acquisition strategies. NorthView Acquisition Corporation's success depends on its ability to differentiate itself and secure a favorable merger opportunity in a competitive landscape.
Who Are NVAC's Key Customers?
- Private healthcare companies seeking to go public.
- Investors in NorthView Acquisition Corporation's IPO.
- Shareholders of the merged entity.
Company Profile
NorthView Acquisition Corporation operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Jack E. Stover CPA. NVAC has traded publicly since 2022.
Financial Health
NorthView Acquisition Corporation's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for NorthView Acquisition Corporation stands at 154.2%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching.
NVAC Valuation & Market Position
With a $13.4M market cap, NorthView Acquisition Corporation sits in the micro-cap segment of the market.
NVAC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Experienced management team.
- Dedicated focus on the healthcare sector.
- Access to capital through the IPO.
- Flexibility to pursue various transaction structures.
Bear Case
- Lack of current operations.
- Dependence on identifying and acquiring a suitable target.
- Competition from other SPACs.
- Potential for dilution through future equity offerings.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
NVAC Latest News
No recent news available for NVAC.
Classification
Industry Shell CompaniesLeadership: Jack E. Stover CPA
CEO
Jack E. Stover is a Certified Public Accountant (CPA) with extensive experience in financial management and corporate strategy. His background includes holding leadership positions in various financial institutions and advisory firms. Mr. Stover has a proven track record of successfully guiding companies through complex financial transactions and strategic initiatives. His expertise in accounting, auditing, and financial analysis makes him well-suited to lead NorthView Acquisition Corporation in its pursuit of a merger or acquisition.
Track Record: Under Mr. Stover's leadership, NorthView Acquisition Corporation has focused on identifying potential merger targets within the healthcare sector. His strategic decisions have been centered on evaluating companies with strong growth potential and innovative technologies. While the company has not yet completed a merger, Mr. Stover's efforts have been instrumental in building a pipeline of potential acquisition targets and positioning the company for future success.
NVAC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that NorthView Acquisition Corporation may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory oversight as those listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Limited liquidity.
- Higher price volatility.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the management team's experience and track record.
- Evaluate the company's business plan and growth prospects.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Check for any regulatory actions or investigations.
- Presence of a qualified management team.
- Clear business plan and strategy.
- Compliance with OTC market regulations.
- Independent audit of financial statements.
- Active communication with shareholders.
Common Questions About NVAC (Financial Services)
What happened to NorthView Acquisition Corporation (NVAC) stock?
NorthView Acquisition Corporation (NVAC) no longer trades on public markets. It was delisted in July 2025. The figures below are historical and are not a current quote.
Can I still buy NVAC shares?
No. NVAC stopped trading on public markets in July 2025, so the shares are not available through a broker. Anything you see quoted for NVAC elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before NVAC stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to NorthView Acquisition Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does NorthView Acquisition Corporation do?
NorthView Acquisition Corporation is a special purpose acquisition company (SPAC), also known as a blank check company. It was formed to raise capital through an initial public offering (IPO) with the intention of acquiring or merging with an existing private company, primarily in the healthcare sector.
What do analysts say about NVAC stock?
As of March 17, 2026, there is limited analyst coverage on NorthView Acquisition Corporation (NVAC) due to its nature as a shell company awaiting a merger. Any potential valuation metrics and growth considerations are entirely dependent on the future target company that NVAC may acquire.
What are the main risks for NVAC?
The main risks for NorthView Acquisition Corporation (NVAC) stem from its status as a shell company. These include the risk of failing to find a suitable merger target within the allotted timeframe, which could lead to liquidation and loss of investment. There's also the risk that the acquired company may underperform expectations, leading to a decline in stock value post-merger.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- The analysis is limited by the lack of current operations and financial data for NorthView Acquisition Corporation.